Tai'an Central Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Tai'an China (1993)

Organization Overview

First Clinical Trial
2014
NCT02412319
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Tai'an Central Hospital | Taian Central Hospital | Taian City Central Hospital | Tai'an People's Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Aplastic (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Irritable Bowel Syndrome (Phase 4)

Leukemia (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 23